glp 1 drugs pancreatitis Enzyme Rise May Link GLP-1, The GLP-1 Agonists and Obesity:
Description
Developing drugs for metabolic dysfunction-associated steatohepatitis (MASH) has been a surprisingly challenging task
If GLP-1s are going to be treated like chronic therapies, we need a model that prioritizes durability and simplicitynot just a temporary discount.
PMID 25470100
How would the addition of a GLP-1RA compare to other second-line add-on therapies in improving management of the T2DM
Results: GLP-1 RAs demonstrate pleiotropic effects through fundamental cellular mechanisms, including enhanced mitochondrial function, anti-inflammatory actions, improved cellular quality control, and comprehensive metabolic regulation
81,107,109 Tanzeum was discontinued by GlaxoSmithKline (GSK) in 2017, primarily due to economic factors
